IMS Health raises $1.3B in NY IPO

Share this article:
IMS to go public, says aquisitions possible
IMS Health raises $1.3 billion in its New York IPO.

IMS Health raised $1.3 billion last month in its New York IPO. The company, which analysts expected would see shares go for between $18 and $21, sold 65 million shares at $20, according to VentureBeat.com.

Formerly public, IMS went private in 2010, after TPG Capital, Canada Pension Plan Investment Board (CPPIB) and Leonard Green & Partners bought it for $5.2 billion, including debt. After the offering, TPG's stake was set to be cut 50% from 62.2%, without underwriters exercising their full option.

The Danbury, CT-based company said it plans to use the offering's net proceeds for debt financing and general corporate purposes.

IMS's operating income rose to $276 million in the nine months ended September 30, 2013, from $173 million a year earlier. Revenue rose 4% to $1.9 billion.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters